DIA428.38+4.41 1.04%
SPX6,000.36+61.06 1.03%
IXIC19,529.95+231.50 1.20%

16 Stocks Moving in Wednesday's Pre-Market Session

Gainers Troika Media Group, Inc. (NASDAQ: TRKA) rose 27.3% to $2.05 in pre-market trading after surging around 9% on Tuesday. The company, last month, said it swung to a loss in the fourth quarter.
Benzinga·10/20/2021 11:05:55
Listen to the news

Gainers

  • Troika Media Group, Inc. (NASDAQ:TRKA) rose 27.3% to $2.05 in pre-market trading after surging around 9% on Tuesday. The company, last month, said it swung to a loss in the fourth quarter.
  • Xiaobai Maimai Inc. (NASDAQ:HX) rose 22% to $11.60 in pre-market trading after jumping around 43% on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO.
  • Sesen Bio, Inc. (NASDAQ:SESN) rose 16.8% to $1.18 in pre-market trading following a company announcement that the FDA granted its request for a Type A Meeting to discuss the issues brought up within the complete response letter (CRL) response to Vicineum.
  • Valneva SE (NASDAQ:VALN) rose 9.1% to $38.63 in pre-market trading after dropping 10% on Tuesday. The company recently reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.
  • IceCure Medical Ltd (NASDAQ:ICCM) shares rose 7.6% to $6.50 in pre-market trading. IceCure Medical recently reported updated regulatory strategy in China for the IceSense3® system to treat cancerous tumors with cryoablation.
  • Bit Brother Limited (NASDAQ:BTB) rose 6.6% to $1.06 in pre-market trading after gaining around 5% on Tuesday.
  • Greenpro Capital Corp. (NASDAQ:GRNQ) rose 6.4% to $0.9950 in pre-market trading after declining 6% on Tuesday.
  • MICT, Inc. (NASDAQ:MICT) rose 6.2% to $1.54 in pre-market trading after gaining around 6% on Tuesday.
  • Camber Energy, Inc. (NYSE:CEI) rose 5.3% to $1.78 in pre-market trading after surging around 22% on Tuesday.
  • Ocugen, Inc. (NASDAQ:OCGN) rose 5.2% to $8.76 in pre-market trading. Ocugen will present pre-clinical data for OCU410 at 2nd Annual Dry AMD Therapeutic Development Conference Oct. 20.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Novavax, Inc. (NASDAQ:NVAX) shares fell 19.7% to $128.85 in pre-market trading. Novavax, is expected to report its Q3 financial results and operational highlights on Thursday, November 4, 2021.
  • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 17% to $6.46 in pre-market trading. Vinco Ventures announced its CEO and Chairman Christopher Ferguson has resigned from the company, effective Oct. 25, 2021.
  • ATI Physical Therapy, Inc. (NYSE:ATIP) shares fell 12.6% to $3.19 in pre-market trading after the company issued Q3 sales guidance below estimates.
  • ION Geophysical Corporation (NYSE:IO) fell 7.1% to $2.11 in pre-market trading. ION Geophysical recently issued Q3 sales guidance above estimates.
  • Grove, Inc. (NASDAQ:GRVI) shares fell 6.4% to $7.15 in pre-market trading after jumping around 24% on Tuesday. The company’s board recently approved up to 1 million share repurchase authorization.
  • Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) fell 5.6% to $3.06 in pre-market trading. Entasis Therapeutics recently announced topline results from its Phase 3 ATTACK trial. SUL-DUR met its primary efficacy endpoint.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.